Combined treatment regimen shows early promise in eliminating metastatic prostate cancer
Can't see this email? View it online
   
  April 20, 2017  
  Prostate Cancer  
  The latest prostate cancer news from News Medical  
 Combined treatment regimen shows early promise in eliminating metastatic prostate cancerCombined treatment regimen shows early promise in eliminating metastatic prostate cancer
 
In the past, all forms of metastatic prostate cancer have been considered incurable. In recent years, the FDA has approved six drugs for men with metastatic disease, all of which can increase survival.
 
 
 Quality of life for prostate cancer patients varies by type of treatment, study revealsQuality of life for prostate cancer patients varies by type of treatment, study reveals
 
Quality of life after prostate cancer treatment varies by the type of treatment patients receive, a new study reveals.
 
   Bacteriophages may help combat antibiotic-resistant 'superbugs'Bacteriophages may help combat antibiotic-resistant 'superbugs'
 
Viruses that specifically kill bacteria, called bacteriophages, might one day help solve the growing problem of bacterial infections that are resistant to antibiotic treatment.
 
 Addressing unmet needs in prostate cancer
 
Addressing unmet needs in prostate cancerProstate cancer is the second most diagnosed cancer globally with over a million men diagnosed worldwide. We are fortunate in that better diagnostic techniques and better awareness means that men are often being diagnosed earlier, which gives them a better chance of being cured.
 
 
 Differences found in cancer occurrence within African and US born blacks
 
Differences found in cancer occurrence within African and US born blacksThe cancer profile of African-born blacks differs from that of United States-born blacks and varies by region of birth, according to a new study. The study, appearing in CANCER, suggests differences in environmental, cultural, social, and genetic factors, and points to an opportunity to study the risk factors associated with the cancer burden in African-born blacks to help create targeted interventions.